|
|
||||||||
|
|
|||||||||
|
|
Oncology-Clinical Diagnosis: Solid TumorsClinical Diagnosis-Solid Tumors Posters |
1 Div Nucl Med; 2 Div Endo, Wash Hosp Ctr, Washington, District of Columbia
1507
Objectives: To compare the ability of I-124 PET imaging vs diagnostic I-131 planar imaging in detecting metastatic WDTC.
Methods: Prospectively, patients (pts) were selected for I-124 imaging who (1) had histologically proven WDTC, (2) were suspected of having metastatic WDTC (e.g.
Tg levels, + recent FNA, suspicious enlarging mass), and (3) were referred for I-131 whole body dosimetry (DM). The prescribed activity was 1-2 mCi and 1.7 mCi for I-131 and I-124, respectively. Pts who were prepared with withdrawal (WD) had I-131 DM performed first (n=5). Those prepared with rh-TSH injections were randomized to receive I-131 or I-124 first (n=9). For each image, 1 reader (DVN) categorized every focus of I-131 and I-124 radioiodine uptake (RAIU) as 1=definite physiological uptake/artifact, 2=most likely physiological uptake/artifact, 3=indeterminate, 4=residual thyroid tissue/metastases (mets) in the neck/bed, 5=most likely distant mets, or 6=definite distant mets. Categories 4, 5 and 6 were considered positive (+). When available, foci were correlated with other diagnostic studies.
Results: Of the 14 pts, 5 pts (33%) had more + foci on I-124 than on I-131, of which 3 (60%) had mets confirmed by CT in 1 or more of the additional + I-124 foci. I-124 images were identical to I-131 in 8 pts (7 with no + foci; 1 with 2 + foci each). A total of 89 + foci were identified on either I-124 or I-131. I-124 identified 40 + foci not seen on I-131; one pt had one + focus on I-131 not seen on I-124, which has not yet been confirmed as a met.
Conclusions: Relative to I-131 planar imaging, I-124 PET imaging identified significantly more foci of RAIU suggestive of residual tissue or metastatic WDTC.
Research Support: Grants from Genzyme and Latham Fund
| ||||||||||||||||||||||||||||||||||||||